Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
22 results
D3.84 - Delayed hypersensitivity to hydroxychloroquine with positive patch test
D3.85 - Evaluation of a new Multiplex Allergen Test Kit for the simultaneous detection of allergen specific IgE
D3.87 - Assessing the agreement between skin prick test and specific-IgE for ten common food allergens in infants
D3.89 - Unexpected Culprit: The Role of Acrylates in Recurrent Anaphylaxis and Antibiotic Hypersensitivity
D3.91 - Safety of Skin Prick Tests: more than 30 years of spontaneous data from real practice
D3.94 - Optimizing the Diagnosis and Treatment of Psoriasis Associated with Streptococcal Infection
D3.88 - 5-Year Metal Patch Testing Analysis of a Portuguese Immunology an Allergology Center: Allergen relevance and Cluster identification
D1.309 - Association of Antenatal Corticosteroids with Risk of Autoimmune Diseases in Children: a Nationwide Cohort Study
D1.308 - Case report: challenges in a long-term prophylaxis in hereditary angioedema (HAE)
D1.310 - Phenotypes of patients with Hereditary Angioedema (HAE): a case series
D1.311 - Treatment Dilemmas in CARMIL2 Deficiency
D1.312 - Acquired C1-inhibitor deficiency angioedema treated with lanadelumab: a case series
D1.313 - Inborn Error of Immunity Associated Inflammatory Bowel Disease at a Tertiary Care Center
D1.315 - Classifying the unclassifiable: diagnosis, characterization, and management of adults with unclassified primary antibody deficiency (unPAD)
D1.316 - Lessons Learned from the Diagnosis and Management of a female pediatric patient with NCF2 Mutations and Chronic Granulomatous Disease
D1.317 - A Retrospective Analysis of Dengue-Associated Hemophagocytic Lymphohistiocytosis in a Dengue-Endemic Country
D1.318 - Extending Lanadelumab Dosing Intervals to Every 4 Weeks With Sustained Effectiveness for Hereditary Angioedema Attack Prevention: An Analysis From the Final ENABLE Study Data
D1.319 - The Silent Threat of Hereditary Angioedema in Children: Single Center Experience
D1.322 - A Prescription for Lower Immunity: The Hidden Cost of Certain Psychiatric Medications
D1.323 - Concurrence of essential mixed cryoglobulinemia and cold agglutinin disease: a matter of shared light chains. Case series and literature review
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download